Cargando…
Targeted drugs for systemic therapy of lung cancer with brain metastases
Brain metastases are very common in lung cancer patients. The condition of these patients is complicated and difficult to treat, and adverse reactions following treatment can affect the nervous system, which severely reduces quality of life. Lung cancers are categorized as small cell lung cancers an...
Autores principales: | Sun, Ya-Wen, Xu, Jian, Zhou, Jun, Liu, Wen-Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797064/ https://www.ncbi.nlm.nih.gov/pubmed/29435193 http://dx.doi.org/10.18632/oncotarget.23616 |
Ejemplares similares
-
Primary systemic therapy for patients with brain metastases from lung cancer ineligible for targeted agents
por: Nieder, Carsten, et al.
Publicado: (2022) -
Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy
por: Huang, Mian, et al.
Publicado: (2023) -
Targeted Therapies in Brain Metastases
por: Lin, Nancy U.
Publicado: (2013) -
Intracranial Efficacy of Systemic Therapy in Patients with Asymptomatic Brain Metastases from Lung Cancer
por: Sun, Min-Gwan, et al.
Publicado: (2023) -
Management of brain metastases in lung cancer: evolving roles for radiation and systemic treatment in the era of targeted and immune therapies
por: Myall, Nathaniel J, et al.
Publicado: (2021)